The table below shows Coherus BioSciences, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$42.17M
$26.39M
$1.22M
$211.04M
$326.55M
$475.82M
Cost of revenue
$13.81M
$8.73M
$438.00K
$70.08M
$57.59M
$37.67M
Gross profit
-
-
-
-
-
-
R&D
$108.89M
$91.83M
$96.11M
$199.36M
$363.11M
$142.76M
SG&A
CHRS annual revenue (10-K history)
Coherus BioSciences, Inc. reported annual revenue of $42.17M for fiscal year 2025. That is up 59.8% from $26.39M in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $190.11M (FY 2016) to $42.17M. Figures come from the company's audited annual reports as filed with the SEC.